Patents by Inventor Thierry Rose

Thierry Rose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A HYBRID SUPPLY MONITORING SYSTEM FOR A RADAR DEVICE
    Publication number: 20240125897
    Abstract: An integrated circuit (IC) includes circuitry in a plurality of power domains for transmitting and/or receiving radar chirp frames and first and second monitoring systems for monitoring supply voltages of a first and a second subset of the plurality of power domains, respectively. The first subset is monitored outside of a time window during which a chirp frame is transmitted and/or received utilizing circuitry of the IC, and the second subset is monitored during the time window. The first monitoring system includes an output for an error signal indicating a supply voltage in the first subset does not comply with a first voltage parameter. The second monitoring system includes a unique monitoring circuit for each power domain in the second subset, and each unique monitoring circuit includes an output for an error signal indicating a supply voltage in the second subset does not comply with a second voltage parameter.
    Type: Application
    Filed: October 10, 2023
    Publication date: April 18, 2024
    Inventors: Cristian Pavao Moreira, Matthias Rose, Thierry Mesnard
  • Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins
    Patent number: 11938199
    Abstract: The present invention is in the field of bioluminescence in biology and/or medicine. In particular, the invention provides imidazopyrazine derivatives, processes for preparation thereof, and their uses as luciferins.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: March 26, 2024
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Yves-Louis Janin, Eloi Paul Coutant, Vincent Hervin, Glwadys Gagnot, Yves Jacob, Sophie Goyard, Thierry Rose
  • LUCIFERASE LINKED IMMUNOSORBENT ASSAY
    Publication number: 20230145894
    Abstract: The present invention relates to a fusion protein comprising: —a N-terminal domain which comprises an antibody which is a variable domain of a camelid heavy-chain antibody (VHH) or a single chain variable fragment (scFV) and which is directed against an immunoglobulin and —a C-terminal domain which comprises a polypeptide with a luciferase activity: —having the amino acid sequence SEQ ID NO: 1 or —having at least 80% amino acid sequence identity to the amino acid sequence SEQ ID NO: 1.
    Type: Application
    Filed: April 26, 2021
    Publication date: May 11, 2023
    Inventors: Thierry Rose, Sophie GOYARD, Laurent Lionel REBER, Yves JANIN
  • THERAPEUTIC METHODS AND COMPOSITIONS
    Publication number: 20230038788
    Abstract: Methods for diagnosing or treating immune disorders in a subject are provided. The methods are based on the detection or modulation of Refractory state Inducing Factor (RIF).
    Type: Application
    Filed: June 14, 2022
    Publication date: February 9, 2023
    Inventors: JACQUES THEZE, THIERRY ROSE, FLORENCE BUGAULT
  • Therapeutic methods and compositions
    Patent number: 11365264
    Abstract: Methods for diagnosing or treating immune disorders in a subject are provided. The methods are based on the detection or modulation of Refractory state Inducing Factor (RIF).
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: June 21, 2022
    Assignee: INSTITUT PASTEUR
    Inventors: Jacques Theze, Thierry Rose, Florence Bugault
  • IMIDAZOPYRAZINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, AND THEIR USES AS LUCIFERINS
    Publication number: 20200129644
    Abstract: The present invention is in the field of bioluminescence in biology and/or medicine. In particular, the invention provides imidazopyrazine derivatives, processes for preparation thereof, and their uses as luciferins.
    Type: Application
    Filed: April 30, 2018
    Publication date: April 30, 2020
    Inventors: Yves-Louis JANIN, Eloi Paul COUTANT, Vincent HERVIN, Glwadys GAGNOT, Yves JACOB, Sophie GOYARD, Thierry ROSE
  • THERAPEUTIC METHODS AND COMPOSITIONS
    Publication number: 20160311926
    Abstract: Methods for diagnosing or treating immune disorders in a subject are provided. The methods are based on the detection or modulation of Refractory state Inducing Factor (RIF).
    Type: Application
    Filed: December 22, 2014
    Publication date: October 27, 2016
    Inventors: JACQUES THEZE, THIERRY ROSE, FLORENCE BUGAULT
  • PEPTIDES OF IL-2
    Publication number: 20100273723
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: January 21, 2010
    Publication date: October 28, 2010
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2
    Patent number: 7704490
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: April 27, 2010
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2
    Patent number: 7662368
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: February 16, 2010
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2
    Publication number: 20070048302
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: July 28, 2006
    Publication date: March 1, 2007
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2
    Patent number: 7101965
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: September 5, 2006
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20060018873
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: June 28, 2005
    Publication date: January 26, 2006
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof
    Patent number: 6929791
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: August 16, 2005
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Patent number: 6825334
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: November 30, 2004
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20040202661
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: December 5, 2003
    Publication date: October 14, 2004
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20020044935
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: February 6, 2001
    Publication date: April 18, 2002
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie